Biomedical and biochemical tools of förster resonance energy transfer enabled by colloidal quantum dot nanocrystals for life sciences by Safak Seker U.O. & Volkan Demir H.
Biomedical and Biochemical Tools of
F€orster Resonance Energy Transfer Enabled
by Colloidal Quantum Dot Nanocrystals
for Life Sciences
14
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1 Definition of the Topic
Semiconductor quantum nanocrystals (NCs) provide the ability to control and fine-tune
peak emission wavelength using the size effect, with a broad optical absorption band
(excitation window) increasing toward UV wavelength range. Quantum dots with
different peak emission wavelengths can be excited at the same wavelength and offer
longer fluorescence lifetimes, which make them desirable donor molecules for F€orster
resonance energy transfer (FRET)-based applications. In this chapter, the tools of
FRET using these quantum dot nanocrystals in life science applications are addressed.
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2 Overview
F€orster resonance energy transfer arises from the dipole–dipole interaction of
donors and acceptors in their close proximity (typically less than 10 nm). FRET-
based applications have been widely used in life sciences for a long time, especially
utilizing fluorescent proteins and organic dyes as the donors and/or acceptors.
FRET-based biological applications range from biosensing of a target molecule
to the imaging of the transportation of a molecule within a cellular compartment.
With the recent developments and improvements in nanotechnology, quantum dot
nanocrystals have become the next generation fluorophores with their size-tunable
emission properties and broadband absorption properties.
Quantum dot nanocrystals can be synthesized using both solvent and aqueous
synthesis approaches. To conjugate the quantum dot nanocrystals with biomole-
cules and dye acceptors, surface functionalization is crucial. The surface functiona-
lization may be carried out using a number of different approaches. The most
popular chemical approach is the formation of carboxyl groups on the quantum
dot surface by adding ligands during synthesis and activation of the carboxyl groups
using carbodiimide chemistry based on NHS (N-hydroxysulfosuccinimide)/EDC
(1-ethyl-3-(3-demethylaminopropyl)carbodiimide) activation. Another approach
for the biomolecule conjugation to quantum dots relies on using conventional
streptavidin-biotin interaction. Also, metal-affinity-based conjugation of biomole-
cules, especially proteins, is of great interest because of the simple application of
this method. Thus far the protein-, peptide-, and DNA-conjugated quantum dots
have been utilized in FRET applications for biosensing and imaging techniques.
In this chapter, we present how to utilize biomolecule-quantum dot conjugates in
FRET applications for life sciences, which promise a number of new possibilities
for biosensing and imaging.
3 Introduction
To track intracellular and extracellular events, many different labeling techniques
have been employed. These include labeling the target biomolecule using
a fluorescent reporter. This fluorescent molecule can be either another biological
molecule such as a fluorescent protein and peptide, or more commonly a chemical
dye molecule [1, 2]. Many dye molecules have been successfully designed, syn-
thesized, and attached to certain biomolecules to track changes and processes in
intracellular and extracellular environment [3, 4]. Many of these dye molecules
have also been successfully utilized to make biochemical assays to determine the
amount of a given molecule quantitatively and qualitatively [4, 5]. Although these
approaches worked well in most cases, there have been certain limitations, which in
turn make their potential limited for understanding the biological complexity and
underpinning mechanisms. Most of the dye-protein labeling approaches need to be
normalized with respect to the number of molecules used in the extracellular assays.
This makes it hard to follow the changes upon interacting a labeled molecule,
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as there is only one signal but many possible interactions. For biosensing applica-
tions, using only one labeled species can be problematic to track changes upon
molecular interactions. Following up a single signal can cause nonspecific interac-
tion errors. Considering all these factors, a more powerful technique, F€orster
resonance energy transfer – FRET, has found a large area of usability in biolabeling
applications [6]. F€orster resonance energy transfer, also sometimes referred to as
the fluorescence resonance energy transfer in the community, is a phenomenon that
takes place through the nonradiative transfer of the electronic excitation energy
from an electronically excited donor to a fluorescence acceptor, which can only
occur if the distance between the donor and acceptor species is smaller than twice
F€orster radii (typically corresponding to a distance of less than 10 nm) and if the
emission of the donor spectrally matches the absorption of the acceptor. This
phenomenon was first explained by Theodor F€orster in 1948. Since then, FRET
has been widely used in biological and biochemical applications, among which are
protein–protein interactions, conformational change of proteins, DNA hybridiza-
tion, and receptor–ligand binding [7].
For the protein–protein interaction studies, if the interaction is being carried out in
an intracellular environment, generally both of the molecules are fused with
a fluorescent protein such as green fluorescent protein (GFP) and red fluorescent
protein (RFP), and through the change in FRET signal, the strength of the interaction
can be quantified. Mostly, the FRET signal in intracellular protein–protein interaction
type of these studies is monitored under fluorescence microscopy. Similarly, another
approach relies on labeling both of the interacting molecules using conventional dye
molecules that possess a good spectral overlap for FRET application. These
approaches can be useful especially for extracellular FRET-based bioassays.
One of the popular utilization of FRET signal is for monitoring changes in the
structure of a protein. In this approach, a protein molecule must be labeled in a site-
specific manner with suitable fluorescence dyes, because any structural change that
results in the folding of the protein will lead to a distance change between the dye
molecules, and as long as the separation between the dye molecules satisfies the FRET
conditions, one can easily correlate the structural rearrangement of the protein with the
FRET signal. This event can be calibrated with reference molecules in such a way that
FRET signal can be used as a molecularly sensitive nanoruler [8]. Similarly, upon the
denaturation–renaturation of the proteins, the distance between the fluorescent labels
can be changed, which can be followed through the change in the FRET signal [9].
Ligand–receptor binding was also characterized using FRET processes, where both
ligands–receptors were labeled using fluorescent dyes [10]. This approach is now also
widely utilized to analyze the molecular interaction in biological systems.
FRET applications have been carried out using a range of different materials
dominantly including organic dyes, natural fluorophores (tryptophan, tyrosine, and
phenylalanine), and fluorescent proteins, and enzyme catalyzed bio- and
chemoluminescence reactions were also used [11–13]. However, one of the prob-
lems in most of these applications was the short fluorescent lifetime of the given
molecules and materials, for which some other alternative dyes and materials were
utilized [6].
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The number of recent studies conducted to use nanoparticles in FRET studies is
also increasing. Mostly metal- (e.g., gold) and semiconductor- (e.g., silicon) based
nanoparticles as well as luminescent quantum dot nanoparticles have been used for
their exceptional size-tunable properties [14]. With these, innovative improvements
in nanotechnology, especially quantum dot nanocrystals, have been investigated to
replace the currently available organic dye molecules. Compared to the organic dye
molecules, these quantum dots have superior characteristics such as the size-
tunable photoluminescence, relatively sharp emission spectrum, broad adsorption
spectrum, and large Stokes shift, which make their emission band far from their
absorption edge [15–17]. Using these unique properties of the quantum dots, they
can be tuned to provide stronger spectral overlaps with a certain type of organic,
natural, or inorganic acceptor. Today, many quantum dot nanocrystals, which can
be utilized as FRET donors, are available in the market with a wide range of peak
emission wavelength options. Also, the synthesis of these quantum dots can be
easily achieved using the simple well-established recipes [18].
The applications of the quantum dot nanocrystals in biological and biomedical
research have been covered in some other previous review papers and book
chapters. However, in this chapter, rather than a general overview of the applica-
tions of the quantum dot nanocrystals, a more focused route into the FRET-based
applications of the quantum dot nanocrystals is considered. This focused coverage
aims at providing a rich source on the quantum dot-enabled FRET-based applica-
tions carried out for life sciences in the literature. This is especially important for
a researcher in the biomedical and biotechnological research areas to envision novel
applications exploiting quantum dot-based FRET as a powerful tool.
This chapter aims to cover the utilization of quantum dot-enabled FRET in
biomedical and biochemical applications. In this sense, we are giving an overview
starting from the basics of the quantum dots to the advanced applications of
quantum dot-enabled FRET in life sciences by covering latest literature. This
chapter starts with the synthesis and surface functionalization of the quantum dot
nanocrystals, which is the key concept for their utilization in FRET-based pro-
cesses. Subsequently, the use of these quantum dots is presented for FRET appli-
cations under two main titles, which are the most common applications of FRET
processes: the biosensing and the bioimaging. Having different target molecules
and utilizing different types of molecular recognition elements, biosensing appli-
cations are grouped as the antibody, protein, and nucleic acid-based applications.
4 Experimental and Instrumental Methodology
4.1 FRET Using Quantum Dot Nanocrystals
4.1.1 Semiconductor Quantum Dot Nanocrystals Synthesis
The first step toward the discovery and realization of the solution-phase formation
of the colloidal quantum dots was taken just after the demonstration of the quantum
confinement effect in semiconductor crystals. It was found that semiconductor
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nanocrystals can be formed within the micellar structures. This first approach
included the synthesis of the semiconductor nanocrystals at the water-oil interface
using a surfactant. The researchers showed that by addition of the metal salts, one
can easily synthesize the quantum dots within the room temperature limits; how-
ever, these initial attempts led to the formation of nanocrystals with poor crystalline
structures in the early times [19].
Quantum dot nanocrystals are made of many different semiconductor materials,
e.g., CdSe, ZnSe, CdZnSe, PbS, and InP, just to name a few. Later after the initial
attempts for the synthesis of the quantum dot nanocrystals, Bawendi et al. demon-
strated that high-quality quantum dot nanocrystals with high quantum yield and
narrow size distribution can be obtained through a hot injection synthesis at high
temperatures, which is considered as a revolutionary milestone in the synthesis of
quantum dot nanoparticles [20, 21]. In this reaction scheme, the precursor materials
which are organometallic precursors were injected into a boiling coordinating
solvent, e.g., trioctylphosphine (TOP) and trioctylphosphine oxide (TOPO). This
process results in the thermal decomposition of the precursor materials and the
monomers form the first nucleus of the quantum dot nanocrystals. Following the
nucleation by further addition of the precursor monomers from the solution,
the crystal growth is achieved. In the mean time, further newly added monomers
are incorporated onto the existing nuclei instead of forming new nuclei because of
their lower unsaturated concentrations. As soon as the monomer concentration is
decreased to a certain level, the growth of nanoparticles continues the Ostwald
ripening process. In this process, the smaller particles with higher surface tension
may dissolve and contribute to the growth of larger particles. This continues until
the system is saturated by the formed quantum dot nanocrystals.
The formation of quantum dot nanocrystals can be controlled by the addition of
certain surfactants and ligand molecules. The longer the reaction continues, the
larger particles are formed. Because the size controls the peak emission wavelength
of the quantum dot nanoparticles, one can optimize the reaction time to obtain
quantum dots emitting at a desired wavelength. Cleaning of the synthesized
nanocrystals is also important to remove the unreacted reagents, as there might be
a high amount of acids, metals, and amines left unreacted in the solution. The
synthesized nanocrystals are typically characterized using transmission electron
microscopy, x-ray photoelectron spectroscopy, and wide-angle x-ray diffraction
spectroscopy. Besides these, optical characterization of the particles must be carried
out using absorption and fluorescence spectroscopy [22, 23].
Water is the crucial medium for all life forms and biological materials. To use
synthesized nanocrystals in aqueous environments, there are two methods: one is to
synthesize the quantum dot nanocrystals directly in an aqueous environment and
the other is through the ligand exchange of solvent-based quantum dots. The
successful synthesis of the aqueous quantum dot nanocrystals made of CdTe was
first achieved by Nozik and Welles. During their synthesis of CdTe nanocrystals,
Nozik et al. used 3-mercapto-1,2-propanediol and hexametaphosphate as the stabi-
lizing agents. Alternatively, Welles et al. introduced different thiols such as
mercaptoethanol and 1-thioglycerol in their aqueous synthesis [24].
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Capping CdTe nanocrystals with TGA also makes it easy for their surface
modification. Later, using aqueous routes of nanocrystals, various materials were
synthesized; CdSe, CdS, CdTe, and HgTe are some of the aqueous NCs. Also, by
applying different capping agents, especially thiols, the quantum efficiency of
aqueous nanocrystals was increased up to 40–60% range. CdTe is now the most
typically used material to make aqueous quantum dot nanocrystals, which has
found many applications because of its simple synthesis while avoiding the need
for any further modification toward water solubility. CdTe nanocrystals are syn-
thesized from a Cd salt, most popularly from Cd (ClO4).6H2O. In the aqueous
synthesis of CdTe, the salt is dissolved in water and a proper amount of thiol is
added for stabilization and the flask is continuously stirred to sustain homogeneity.
The control of the pH of the solution is achieved through dropwise addition of
NaOH. In the mean time, the flask is heated for 30 min aerating with N2. H2Te gas is
flown through the flask with the aid of N2 flow. At the first stage, the precursor of
CdTe is formed, and at the second stage, the precursors are refluxed at 100 C under
open air conditions by the aid of a condenser. During the reflux, CdTe NCs start to
grow. Utilization of Al2Te3 as the Te source can be an alternative way for the CdTe
nanocrystal synthesis, which can be more convenient but more expensive. During
the synthesis of the CdTe nanocrystals, short chain thiols (namely thioglycolic acid,
mercaptoacetic acid, 2-mercaptoethylamine, and cysteamine) with functional
groups (e.g., amine, carboxyl, and hydroxyl) have been utilized [19, 25, 26].
4.1.2 Surface Modification of Quantum Dot Nanocrystals
In order to utilize the quantum dot nanocrystals in FRET applications, strategies for
the conjugation with biomolecules and with certain dye molecules are needed. The
conjugation of the quantum dot nanocrystals allows the dye and quantum molecule
to be kept in the close proximity, which satisfies the nonradiative energy transfer.
Commonly used approaches for the attachment of the fluorophores to a quantum dot
for FRET applications can be grouped as follows.
4.1.3 Electrostatic Interaction of the Quantum Dot Nanocrystals with
Fluorophores
In this approach, the quantum dot nanocrystals interact with the fluorophores
through positively charged–negatively charged group interaction. In their study,
Sun et al. found that aqueous CdTe solutions to yield high FRET efficiency while
interacting with a polymer named poly (vinylcarbazole) in a blend. The interaction
between these species was achieved through electrostatic interaction of the nega-
tively charged CdTe and the positively charged polymer [27] Similarly, Osovsky
et al. investigated the FRET process between CdTe NCs which are modified with
two distinct functional groups, namely, positively charged cysteamine and nega-
tively charged thioglycolic acid [28]. Here, the biomolecules were coupled with the
quantum dots through electrostatic interaction using the charged groups on the
backbone of the biomolecules. Also, quantum dot nanocrystal sensor complexes
built up using single-strand DNA and the attachment of proteins are among the
examples of biomolecule-quantum dot nanocrystals hybrid systems formed through
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electrostatic interactions [29–33]. Although the electrostatic interaction is not very
strong compared to metal affinity or chemical attachments, it is widely used for
building FRET complexes using quantum dots because of the easiness of the
method. However, if more stable structures are needed for FRET-operating sys-
tems, other approaches can be pursued.
4.1.4 Chemical Attachment of FRET Partners to Quantum Dot
Nanocrystals
The outer shell surface of the quantum dots can be modified with amine or
carboxylic acid groups, or during the synthesis of the quantum dot nanocrystals,
these groups can be introduced. During the synthesis, thioglycolic acid can be used
as the ligand at the outer shell and the quantum dots then become decorated with the
carboxyl groups. The carboxylic acid group can be activated using the addition of
EDC (1-ethyl-3-(3-demethylaminopropyl)carbodiimide). This reaction leads to the
formation of O-acylisourea intermediate, which can react easily with the amine
groups on the fluorescent biomolecule or the dye and forms a stable conjugate. In
this reaction to prevent the hydrolysis of another intermediate molecule, NHS
(N-hydroxysulfosuccinimide) can also be employed [34–36]. Amine-functionalized
quantum dots can also be synthesized; for example, cysteamine can be employed as
a capping agent, or via ligand exchange, the quantum dot nanocrystal surface can be
decorated with cysteamine. In this case similar to the –COOH functionalization, the
carboxyl-containing molecule can be activated, and quantum dot nanocrystal can be
conjugated via amine coupling [37].
4.1.5 Metal Affinity Tag Enabled Assembly
Metal affinity tag is a commonly used peptide sequence for purification of the
proteins using an affinity-based chromatography approach. The most common
metal affinity tag is a hexahistidine molecule, which interacts strongly with the
metal atoms. Nickel is the most widely used metal for its strong interaction with the
imidazole groups on the histidine amino acids. However, it was also demonstrated
that it can strongly interact with the semiconductor materials [38]. Especially
fluorescence proteins and dye-labeled proteins tagged with 6xHis have been proven
to form FRET couples with quantum dot nanocrystals. Park et al. investigated to
synthesize thiolated nitrilotriacetate-capped CdSe/ZnS quantum dot nanocrystals,
which were then shown to successfully capture the hexahistidine peptide conju-
gated with TAMRA dye [39]. Boeneman et al. achieved the assembly of
a fluorescent protein mCherry on the surface of CdSe/ZnS NCs using the metal
affinity tag as the linker molecule, which was later utilized in a FRET process
successfully [40].
Other specific interactions were also used to conjugate fluorescent biomolecules
and dye-labeled biomolecules to the quantum dot nanocrystals; for example,
biotin–streptavidin interaction was widely used [41–43]. Other protein purification
tags can also be employed for coupling proteins to the quantum dot nanocrystals,
glutathione S-transferase; FLAG and strep-tag are the most promising ones for
creating a protein-NC FRET couple [44].
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4.2 Characterization Methods of the FRET Process
FRET process can be easily monitored using available fluorescence spectroscopy
and time-resolved spectroscopy instruments. In fluorescence spectroscopy, the
optical intensities of the donor and acceptor were measured separately, and then
the optical intensity level of the mixture facilitating FRET must be measured.
However, because the optical intensity level heavily depends on the molar ratio
of the donor and acceptor in the solution, the optical intensity of the fluorescence
signal must be carefully normalized for the three cases mentioned above. In
fluorescence spectroscopy, only the change in the optical intensity change of the
donor and acceptor molecules can be tracked.
An additional approach is to measure the fluorescence lifetime change of the
donor and acceptor molecules. In this approach using a time-resolved fluorescence
spectroscopy (e.g., time-correlated single photon count systems), the emission
kinetics of the donor and acceptor are monitored and the decay lifetimes are
measured. This leads to a more robust measurement of the FRET process, because
the measurement changes in the emission kinetics are not as sensitive to the amount
of the material that exists in the medium as the steady state measurements [45].
A time-resolved fluorescence spectroscopy tool needs to be equipped with
a gated or pulsed laser source emitting at a suitable excitation wavelength, which
can be used to excite the fluorescent materials subject to FRET process in the
substrate medium. In order to focus the laser beam, a lens system is used and the
beam is passed through a polarizer. Subsequently, the light is passed through
a monochromator with a suitable slit aperture, and the photons can be counted
using a high-precision time-correlated single photon counting system in the case of
time-correlated single photon count systems [26].
5 Key Research Findings
5.1 Quantum Dot Nanocrystals Enabled Biosensors
5.1.1 Antibody–Antigen Interaction Using Quantum Dot Nanocrystal-
Enabled FRET Processes
Nanobiosensors have been developed and/or improved in the last decade with better
sensing capabilities and lower limits of detections [46]. Quantum dot nanocrystals
have been widely used as the signal-generating parts of these sensing systems.
FRET process is the best way to harness the optical properties of QD photolumi-
nescence (PL). Quantum dots are versatile donors for FRET applications, and they
can generate very efficient FRET processes when they are coupled with a proper
acceptor [7, 47, 48]. Today, many researchers are interested in using quantum dots
as donors for FRET applications for their favorable optical properties, which are
mentioned earlier. Especially high-quantum-yield (QY) ratios of these quantum
dots make them popular for FRET applications because a high QY allows for
detecting at longer FRET distances. Also, the sharp and size-tunable emission of
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the quantum dots allows minimizing the cross talk between the acceptor and donor
emission wavelengths during measurements. Quantum dots are ideal for
multiplexed FRET configurations as more than one quantum dot emitting at
different wavelengths can be excited at the same wavelength without an overlap
with their respective PLs [6]. One of the important requirements for the biosensors
is specificity. In this respect, the quantum dots provide very large surface areas
which enable them to be easily functionalized for recognition elements using
a number of different conjugation methods [18].
Quantum dot-based FRET has been used in biosensing applications to monitor
different types of specific biological and biochemical events. In biosensing studies,
one of the most studied and well-established approaches is based on utilizing
molecular recognition elements to detect specific molecules such as antibody–
antigen systems. In an antibody-based sensing system, typically a sandwich type
of assay is utilized to capture an antigen. Here, two antibodies with affinity to the
same target can be used. In this case, the first antibody is labeled with a quantum
dot, and the second antibody, reporter antibody, is labeled with a dye molecule [49].
If a target antigen is added into the solution, it binds both the antibodies, which
finally creates a FRET-controlled quenching of the quantum dot with the dye
molecule, and the loss in PL of the quantum dot depends on the concentration of
the target antigen [50]. This assay configuration may, however, cause some prob-
lems including a possible heterogonous A–D separation due to the bigger size of the
antibody, which can then result in mixed antibody avidity [51]. For example, Wei
et al. tested this configuration by conjugating a monoclonal antibody specific for
estrogen receptor b (ER-b) to a quantum dot emitting at 565 nm and polyclonal
anti-ER-b reporter antibody labeled with Alexa Fluor 633 dye. They characterized
the system by adding ER-b into the solution. The loss in PL of the quantum dot was
observed upon formation of the sandwich. The FRET distance between A and
D was calculated to be 8–9 nm, which is a proof of the larger size of the molecules
[52]. Detection of the FRET signal between an antigen and an antibody can be
improved using a specific separation approach, which was achieved through
a capillary electrophoresis. In their study, Li et al. accomplished the labeling of
mouse IgG and goat anti-mouse IgG with water-soluble CdTe QDs emitting at
532 nm (donor) and 632 nm (acceptor). FRET process was observed by separating
noninteracting and well interacting FRET pairs using CE equipped with
a fluorescence detector [53]. In contrast to this approach, the competition between
a phage display-selected anti-TNT (2,4,6-trinitrotoluene) single-chain Fv fragment
attached to CdSe/ZnS core/shell QDs (emitting at 530, 555, and 570 nm ) and
a quencher dye (Black Hole Quencher-10)-labeled TNT analogue (TNB) was used
to yield FRET-based quenching. As shown in Fig. 14.1, upon binding of TNT
existing in the sample to the scFv fragment around the quenched quantum dot
bound to TNB-BHQ-10, TNB-BHQ-10 was exchanged with TNT, which allowed
a concentration-based increase in the quantum dot emission after termination of the
quenching via FRET process [54].
Proteomic applications of antibodies are of great interest for detection of many
diseases. Autoimmune diseases can be characterized using antibody profiling of the
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disease markers, which is crucial for the diagnosis of the disease at early stages. In
this manner, Sukhanova et al. demonstrated a sandwich-type assay by using the
FRET effect enabled between orange emitting quantum dot nanocrystals and FITC
dye. Quantum dots were assembled on microbeads and covered with a human DNA
topoisomerase I (topol), which was used to detect anti-topol antibodies as they were
one of the markers of systemic sclerosis. After the addition of the human plasma
followed by the addition of FITC-labeled secondary anti-topol antibodies, the
readout gave a FRET signal upon the existence of any anti-topol antibody in the
human blood plasma [55].
5.1.2 Monitoring Nucleic Acid Assembly and Functionality Using
Quantum Dot Nanocrystal-Enabled FRET Processes
Conjugation of the nucleic acids with quantum dot nanocrystals is a popular
approach to build biosensors. Using the FRET process, the quantum dot nanocrys-
tal–nucleic acid conjugates were used to detect the existence of certain nucleic acid
sequences via sequence-controlled hybridization. Also, nucleic acid aptamers were
utilized in this type of applications, which have specific recognition capabilities
toward a specific molecule (e.g., protein, peptide, and DNA) via their
corresponding three-dimensional structure. Compared to the dye-labeled protein-
quantum dot conjugates, the dye-labeled thiolated DNA-quantum dot configuration
makes more sensitive FRET sensors [56].
Molecular beacons are the well-known examples for the quantum dot-nucleic
acid conjugations facilitating FRET process. In a molecular beacon, a single-
stranded DNA (ssDNA) molecule is conjugated to a quantum dot nanocrystal
from one end, and a quencher molecule is attached to the other end. The ssDNA
molecule is generally designed in a way that can hybridize to forming a stem loop at
the end. Generally, this stem-loop sequence contains a specific sequence that targets
another specific region. Upon hybridization of the stem-loop sequence with the
target probe, the stem loop opens and the distance between quantum dot nanocrystal
Fig. 14.1 Schematic of the TNT sensor (a) QD conjugate of the TNT receptor, (b) FRET between
QD and quencher-labeled analogue molecule, and (c) replacement of the quencher-labeled ana-
logue and recovering the QD fluorescent emission (Reprinted with permission from Goldman,
E. R. et al. A hybrid quantum dot-antibody fragment fluorescence resonance energy transfer-based
TNT sensor. J. Am. Chem. Soc. 127, 6744-6751 (2005). Copyright (2005) American Chemical
Society)
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and quencher molecule increases, turning on the emission of the quantum dot upon
the decrease in the FRET efficiency of the quantum dot with the quencher. Cady
et al. studied the optimum conditions of molecular beacon configuration using
quantum dot nanocrystal as the fluorophore (Fig. 14.2).
The attachment chemistry of quantum dot nanocrystal to ssDNA is crucial for
the molecular beacon. Although streptavidin–biotin-based attachment is easy, using
a zero-length linker, EDC chemistry is promising and provides a better fluorescence
intensity. Depending on the emission wavelength of the quantum dot, using a dye
molecule as a quencher is more promising instead of using gold nanoparticles,
although it is a good quencher. However, the spectral overlap with the dye must be
well-defined [57]. Wu et al. demonstrated the importance of the linker to conjugate
DNA molecule to quantum dot after surface treatments for FRET-based sensing
applications on a glass surface. Amine-functionalized DNA was attached to the
carboxyl-containing quantum dots using NHS/EDC chemistry. Using a zero-length
linker, they avoided any possible steric hindrance due to the size of the conjugates
on the glass slide surface, where they achieved a 3 nm quantum dot conjugate in
size and 70% FRET efficiency during DNA detection via specific DNA hybridiza-
tion of the target DNA molecule with a surface-bound reporter [58]. Similarly,
using thiols is also very useful as a linker for quantum dot-DNA conjugates in
FRET applications [56]. Quantum dot molecular beacons were also formed using
quantum dot nanocrystals emitting at different wavelengths, which brought about
a promising approach for the multiplexed quantum dot molecular beacon systems.
In a multicolor quantum dot nanocrystal scheme, molecular beacons were able to
detect a target DNA down to 8 ng in a sample solution, which was comparable to
Fig. 14.2 Schematics of
a molecular beacon and its
working principle
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that of the currently available organic dyes with a higher stability and a lesser
background signal [59].
Single quantum dot-based DNA nanosensors have been very popular since the
demonstration of its first usage. In this scheme, a dye molecule was attached to
quantum dot nanocrystals by using appropriate conjugation chemistry. Cy5 and
quantum dot nanocrystals emitting at 605 were found to have an excellent overlap,
and in most of the following studies, this pair was used for FRET-enabled sensing.
In the demonstration by Zhang et al., this configuration was found to be more
sensitive than a molecular beacon approach [60].
DNA aptamers are molecular recognition elements functioning through their
three-dimensional structures. They were selected using a system called SELEX.
Using an aptamer molecule selected for adenosine triphosphate (ATP) binding,
Chen et al. built quantum dot nanocrystal-enabled FRET-based systems to sense
ATP in solution, which has an alternative configuration. In the nanosensor,
a streptavidin-coated quantum dot nanocrystal (605 nm), a 30-biotin-modified
DNA, 30-Cy5-labeled DNA, and a capture DNA involving an ATP-binding aptamer
that contains specific binding sequences for 30-biotin-modified DNA were used. In
the absence of ATP, the capture DNA was bound to the 30-Cy5-labeled DNA and
30-biotin-modified DNA, which later was bound to the streptavidin-coated quantum
dot nanocrystal complex via biotin. In this first configuration, the bound 30-Cy5-
labeled DNA came into the close proximity with the quantum dot, resulting in the
quenching of the quantum dot due to the FRET process. However, if ATP was
introduced, it competed with the 30-Cy5-labeled DNA and released it. This resulted
in an obvious increase of the quantum dot emission [61].
This alternative approach might be extended into sensing DNA–DNA,
DNA–protein, and DNA–small molecule interactions (e.g., minerals and vitamins).
Moreover, a nanosensor for cocaine detection was realized using a similar
approach based on a DNA aptamer specific for cocaine. This sensor, however,
was built in two different configurations. A quantum dot nanocrystal emitting
at 605 nm was conjugated with a DNA molecule displaying a cocaine-specific
aptamer sequence and could also hybridize with a DNA fragment conjugated
with Cy5. In the absence of the cocaine, the Cy5-conjugated DNA fragment was
bound to the quantum dot nanocrystal conjugated backbone, and the FRET
process between Cy5 and quantum dot nanocrystal causes the quantum dots to be
quenched. Upon the addition of cocaine into the medium, it was bound to the
aptamer sequence which has caused the dissociation of the Cy5-labeled DNA
fragment and triggered the increase of quantum dot PL upon turning down the
FRET process. Furthermore, the same process was improved by introducing
another dye-labeled (Iowa Black RQ) DNA fragment. This secondary fragment
(Iowa Black RQ) DNA can bound to the DNA attached to the quantum dot
nanocrystal and formed a sandwich shown as in Fig. 14.3 in the absence of cocaine
which resulted in quenching the emission of Cy5. In the presence of cocaine, the
aptamer was bound to cocaine, which resulted in the release of Iowa Black
RQ-labeled DNA. After this, the fluorescence of Cy5 became detectable as a sign
of cocaine [62].
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Detection of the platelet-derived growth factor (PDGF) using an aptamer DNA
conjugated with quantum dot nanocrystals was also realized, where the FRET was
switched off and on by the attachment and release of the black hole quencher to the
quantum dot-conjugated DNA sequence upon the absence and existence of PDGF
in the sample [63]. Alternatively, unlabeled DNA can be also captured to its specific
capture agent, and detection of target DNA can be achieved. In this configuration,
the capture DNA was conjugated to a quantum dot nanocrystal using polyethylene
glycol (PGE) linker. PEG linker helped to adjust the distance of capture DNA to
quantum dot nanocrystal, which helped to adjust FRET distance between quantum
Fig. 14.3 Schematic of the cocaine sensor: (a) Signal-off configuration of the QD-based cocaine
sensor, where the QD emission was quenched at first and later increased upon cocaine binding.
(b) Signal-on configuration of the QD-based cocaine sensor, where the QD emission was quenched
upon cocaine binding (Reprinted with permission from Johnson, L. W. & Zhang, C. Y. Single
Quantum-Dot-Based Aptameric Nanosensor for Cocaine. Anal Chem 81, 3051–3055, doi:
10.1021/Ac802737b (2009). Copyright (2009) American Chemical Society)
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dot nanocrystal and dye, ethidium bromide (EtBr), a molecule labeled to target
DNA. To detect the unlabeled DNA, the sample was introduced into the solution
and the hybridization took place. Later, EtBr was added to the solution and it
formed a fluorescent complex with unlabeled DNA. Upon the formation of the
complex, FRET occurred between the quantum dot nanocrystal and the complex,
which gave a rise in the fluorescent emission of ethidium bromide [64]. In another
innovative approach, it was proposed to detect the DNA hybridization using a two-
step FRET system. In this route, a positively charged conjugated polymer was used
as the light-harvesting antenna in the solution. It was bound to negatively charged
CdTe QDs, upon which FRET process took place and the outer surface of
QD-antenna complex became positively charged. This complex was then interacted
with the labeled DNA fragments in solution. The second FRET process took place
between the dye-labeled DNA molecule and quantum dot-conjugated polymer
complex. It was also noted that ssDNA and double-stranded DNA (dsDNA) created
different slopes in linearly increasing ratio of dye to quantum dot nanocrystal
emission intensities because of the difference in their binding strength to
QD-polymer complex [65].
A tumor marker, mucin 1, is a glycoprotein that was expressed on most epithelial
cells. This marker was known to be a good indicator for early cancer diagnosis.
A nanosensor that involved a specific DNA aptamer for a MUC1 was constructed,
where the DNA aptamer was bound to the quantum dot through EDC/NHS chem-
istry. The quencher ssDNA, which involved the Iowa Black quencher dye, was able
to hybridize with the MUC1 DNA aptamer; however, in the presence of MUC1, the
aptamer was unfolded into ssDNA. Therefore, both the quencher ssDNA and
quantum dot-modified ssDNA were able to attach on the aptamer. This hybridiza-
tion brought the quencher DNA and the quantum dot in close proximity resulting in
FRET-enabled quenching of the quantum dot, which was shown to be MUC1
concentration dependent [66].
Besides using chemical conjugation or streptavidin–biotin conjugation, for the
assembly of ssDNA to quantum dot nanocrystals, the electrostatic interaction was
also employed to build FRET facilitating system to probe micrococcal nuclease
activity detection. In this configuration, CdSe/ZnS nanoparticles were
functionalized with an enzyme, lysozyme, to prepare positively charged quantum
dots to assemble a negatively charged dye-labeled ssDNA. The dye-labeled ssDNA
was a substrate for nuclease activity on the outer surface of the quantum dot
nanocrystal. When the complex was brought in contact with the micrococcal
nuclease, the nuclease digested the ssDNA and caused the release of the dye
molecule. This process was monitored as a decrease in the emission of the dye
molecule upon deterioration of the FRET process through nuclease activity [33].
To detect the target DNA more precisely, a DNA binding and cleaving enzyme,
nicking endonuclease, was utilized by Xu et al. In the assay, they used a linker
DNA, which was fully complementary to the target DNA. First, the target DNA and
the linker DNA were brought together and they formed a dsDNA, which had a site
for the endonuclease to recognize. The endonuclease cleaved dsDNA and the target
DNA was released, and this recycle was repeated for many times by resulting in the
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cleavage of many linker DNAs. In the second stage, first the enzyme was denatured,
and then the quantum dot-conjugated probe I DNA and rhodamine B-conjugated
probe II DNAwere added, while the uncleaved linker DNA was hybridized with the
quantum dot nanocrystal-probe I. Subsequently, the hybrid was sandwiched with
rhodamine B-probe II and led to the FRET process. Because the ssDNA target can
be used for many cycles, this assay was found to be capable of DNA detection down
to 1nM level [67].
In addition, for the detection of the target DNA molecules in solution, also the
DNA methylation was probed using a quantum dot-based FRET process in another
approach, which is an important tool to detect cancer and monitor tumor behavior
for targeted therapy. For this purpose, a sensitive and fast methodology was
developed and the established method was called MS-qFRET. In this approach,
the genomic DNA was extracted from the sample and subjected to sodium bisulfite
conversion. First, the reaction converted the unmethylated cytosines to uracil and
the methylated ones were not affected. Second, the sample genomic DNA was
amplified with polymerase chain reaction (PCR) using biotin and organic red-
emitting fluorophore labeled forward and reverse primers. Finally, the
streptavidin-coated nanocrystal was assembled with the biotin and dye-tagged
sample DNA. During the PCR reaction, elongation was interrupted by uracils
(converted from unmethylated cytosines). Thus, the higher ratio of methylation
led to the longer DNA sequence and increased the number of dye molecules that
were attached. Consequently, the methylation ratio was determined from the
quenching of quantum dot nanocrystals upon FRET with the dye molecules within
the close proximity [68]. Suzuki et al. also demonstrated a multipurpose approach
using DNA-conjugated quantum dot nanocrystal system for FRET process, which
aimed at responding to nucleolytic cleavage, DNA polymerization, and pH change.
DNA digestion was monitored upon specific cleavage of the DNA molecule by
a nuclease. However, depending on the construction strategy of the DNA-quantum
dot nanocrystal conjugates, two distinct FRET patterns were observed. In DNA
elongation experiment, upon addition of the Klenow fragments and their elongation
with dye-labeled dUTPs, the increased fluorescence of the quantum dot
nanocrystals was observed. By the attachment of fluorescein dye to the amine-
functionalized quantum dot nanocrystals using Traut’s reagent, a FRET-based
pH-sensitive sensor was constructed [69].
A nanocrystal-based FRET sensor has also been constructed for the detection of
RNA. In their work, Bakalova et al. demonstrated a siRNA sensor to test the
effectiveness and activity of the siRNA fragments with the aim of using them in
RNA interference applications in mammalian cells. For that, they conjugated their
designed siRNA sequence with a cross-linker to the carboxyl-coated quantum dot.
They amplified the mRNA extracted from the target sample and labeled
Cy5-labeled nucleotides, while the mRNA sequence was amplified. Cy5-labeled
mRNA was used as a reporter during the hybridization with the siRNA-modified
quantum dots. If the siRNA fragment is a good candidate for the target mRNA and
hybridizes with the siRNA conjugated to quantum dot nanocrystals, then a FRET
process took place between Cy5 on mRNA and the quantum dot nanocrystal
14 Biomedical and Biochemical Tools 545
conjugated to siRNA. This led to an increase in the emission of Cy5. However,
if the increase in the emission of Cy5 was limited or cannot be detected,
then a mismatch was observed instead of the hybridization. Compared to the
available techniques, this approach is faster and promising as a route for siRNA
screening [70].
Another similar experiment was carried out to test the drug candidates for AIDS,
where the sequence-specific interaction between regulatory protein Rev of HIV
virus and portion of env gene within RNA gene (Rev-responsive element, RRE)
was targeted. Since this interaction is vital for the HIV-1 replication, any attempt to
destroy this interaction may lead to the discovery of new drugs for HIV. With this
motivation, Zhang et al. proposed a sensor, which probes the interaction between
the RRE RNA and a 17-mer peptide derived from Rev. In this configuration, RRE
RNA was labeled with a biotin and later conjugated to the streptavidin-coated
quantum dot emitting at 605 nm. Rev peptide was modified with Cy5 from its
N-terminus. FRET process took place when the Cy5-Rev peptide was bound to the
QD-RRE RNA, with an increase in Cy5 emission. The inhibitory effect of the
proflavin was tested within the system, where the proflavin was expected to
dissociate the Cy5-Rev peptide and decrease the Cy5 emission upon corruption of
the FRET process. However, due to the long red tail of proflavin emission, it was
not possible to see the decrease in emission of Cy5, only the expected increase in
the quantum dot emission was detected. Using correct dichroic and band-pass
filters, the leaking long red tail of proflavin emission was filtered, and a distinct
suppressed emission from Cy5 was obtained when proflavin triggered the dissoci-
ation of Cy5-Rev peptide from RRE RNA-conjugated nanocrystals [71].
Nanocrystal-based FRET research was carried out in solution as the ensemble
measurements. However, it was found that it is possible to enhance FRET signal
between the donor quantum dot and the acceptor dye-attached DNA by using
capillary electrophoresis system. This enhancement phenomenon was observed
because of the deformation of the DNA molecule in the capillary flow [72].
Therefore, it can be useful to search for the methodologies other than these
ensemble measurements to enhance the FRET signal, which is possibly as impor-
tant as the conjugation strategies and linkers to be utilized.
5.1.3 Monitoring Protein Involved FRET Processes
Many applications of biosensors in the literature heavily depend on the utilization
of proteins as the recognition elements of the biosensor of interest [73]. They have
also been utilized in many different FRET applications, and dye-conjugated pro-
teins served as the acceptor or donor molecules. In some of these studies, the
proteins were used without any dye conjugation as they already have a self-
fluorescence originated from amino acids such as tryptophan, tyrosine, and phe-
nylalanine [74, 75]. Sarkar et al. have showed this phenomenon by conjugating
human serum albumin (HAS) to a CdS quantum dot emitting at 510 nm. In this
configuration, when HAS was used as a donor and the quantum dot was as an
acceptor, FRET was facilitated between the tryptophan at the position of Trp214
and the quantum dot. HSA was conjugated to CdS nanocrystal, and upon thermal
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folding/unfolding, which basically modulated the distance between the quantum
dot and Trp214, the steady state PL and time-resolved PL were monitored so that
a structural nanosensor was introduced to track protein-folding intermediates [76].
Since FRET signal occurred at distances lower than 10 nm, it is possible to track the
changes in the conformation of a given protein labeled at appropriate regions with
proper acceptor–donor dye choices. Depending on the conformation of the protein,
the distance between the labeled regions may facilitate FRET, if the conformation
of the protein is changed, and the distance and hence the FRET signal between the
labeled residues change, too. The FRET signal being a nanoruler for the molecular
distances can thus act as a probe for tracking the changes in the protein structure.
The phenomenon of using the structural changes as a probe in conjugation with
an eventual change in the FRET signal was also tested using a model protein,
maltose-binding protein (MBP). Hybrid assemblies of the maltose-binding protein
and quantum dots were shown to be a model biosensor. Maltose-binding
protein from Escherichia coli was attached to quantum dots emitting at 560 nm
via His-tag expressed at the C-terminus of the protein. Later, the MBP-quantum dot
assembly was brought in contact with a dye-labeled maltose analogue molecule,
b-cyclodextrin-QSY9 (dark quencher). Then b-cyclodextrin-QSY9 was bound to
the saccharide-binding site of MBP. Upon binding of the b-cyclodextrin-QSY9, the
quantum dot emission was quenched because of the FRET between b-cyclodextrin-
QSY9 and the quantum dot. When maltose molecules were added to the solution,
the cyclodextrin-QSY9 dissociated and the maltose was bound to the MBPmaltose-
binding site, which gave rise to a signal increase in the quantum dot emission by
virtue of the breakdown of the FRET-based quenching. Consequently, the maltose
concentration-dependent increase in the quantum dot emission was observed.
Utilizing the distance dependence nature of FRET in this configuration, another
approach was put forth. In this technique, possible problems derived from the
donor–acceptor distance restrain can be overcome by the utilization of a multiple
step FRET process. In the second configuration, a two-step FRET process was
employed where MBP was both conjugated to the quantum dot emitting at 530 nm
as the donor and a Cy3 dye as the acceptor emitting at 570 nm. First, the FRET
process took place from the quantum dot to the Cy3 dye, and the second
FRET process occurred between the Cy3 and the b-cyclodextrin-Cy3.5. The second
FRET process resulted in the quenching of the Cy3. Again, addition of maltose
molecules replaced the b-cyclodextrin-Cy3.5, and removal of this molecule was
detected as an increase in the emission of Cy3 in a maltose concentration-dependent
manner. This system was well studied from different aspects including the concen-
tration dependency and the utilization of different donor and acceptor molecules for
optimal functioning [77–79].
Detection of the enzymatic activity by manipulating the FRET process between
the quantum dot and an acceptor molecule was also demonstrated as biosensors.
Protease activity has been one of the most detected phenomena in the biosensor
literature. Also, protease sensors were proposed and implemented using quantum
dot-enabled FRET processes. Chang et al. proposed a structure where gold
nanoparticles (AuNPs) were conjugated with the quantum dot nanocrystal by
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exploiting a peptide linker (GGLGPAGGCG), which was a proper target for
a protease called collagenase XI. Decoration of the surface of the quantum dot
with AuNPs quenched the optical emission. Protease was added into the solution,
and the peptide linkers were digested by collagenase, and the AuNPs were released
from the close proximity of the quantum dots, which led to the increased QD
emission [80]. A similar strategy was also realized to detect type IV collagenase,
which finds applications in tumor invasion and metastasis [81]. In a mechanistic
study, nonradiative quenching of the quantum dots due to the proximal gold
nanoparticles was investigated by means of distance control between the quantum
dots and AuNPs using a peptide sequence (YEHK), which was recognized to
exhibit a rodlike structure, with its second structure enabling a rigid nature. In
this approach, the chain length was changed, and it was concluded that the quantum
dot quenching arose due to the long-distance dipole–metal interaction [82].
Attachment of a dye molecule to a quantum dot is one of the most popular
approaches, which were also explained in the previous section. Similarly, various
peptide sequences were employed as mentioned above. For example, Shi et al.
followed a similar approach and functionalized the surface of quantum dots with
a short peptide (RGDC) terminated with rhodamine Red-X, which quenched the
quantum dot emission in the close proximity. Upon addition of collagenase and
subsequent cleavage of the peptide, FRET was ceased, consequently increasing the
quantum dot emission and quenching of the rhodamine Red-X [83]. Using the same
quantum dot-RGDC-rhodamine Red-X, the effect of the inhibitory activity of
various chemical agents was tested in vitro, where the inhibition of the enzymatic
activity of trypsin was tracked [84]. Clostridium botulinum is attributed to be one of
the well-known pathogens and is being characterized by the extracellular produc-
tion of a toxin called botulinum, composed of a light and heavy chain dimer and
activated just after the posttranslational modifications. Posttranslational modifica-
tions through proteolysis produce the chains by breaking disulfide bond between
them. Sapsford et al. proposed a quantum dot nanosensor to detect the activity, thus
the presence of the toxin. The light chain of the toxin (LcA) was used as the target
molecule, which showed an endopeptidase activity. His-tagged peptide targets were
prepared into which an LcA binding side and a helix spacer were incorporated,
which were labeled with a Cy3 and resultantly caused the quenching of quantum
dots. Sapsford et al. utilized two approaches. The first was the popular metal affinity
conjugation of the peptide to the quantum dot, and they assayed the LcA activity
through the increase in the PL emission of the quantum dots upon detachment of the
Cy3-containing part of the peptide. They also proposed another approach in which
the LcA protein and the substrate peptides containing Cy3 and His-tag were mixed.
Upon proteolytic activity of LcA, the peptide was broken down into parts. There-
fore, upon addition of the QD, undigested peptides were stuck on them. This
attachment caused decrease in the PL emission and read out as the signal for the
LcA activity when compared to the initial peptide concentration [85].
Caspase is an important protease with its particular relevance to cancer research
and one of the key signs of apoptosis. Boeneman et al. constructed a nanosensor to
detect caspase-3 activity in vitro. A cleavage site for caspase-3 protease activities
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was incorporated into a fluorescent protein mCherry through protein engineering,
which was terminated with His-tag sequence to attach the protein to the quantum
dot. The kinetics of FRET process was monitored as a function of proteolytic
activity of caspase-3 in real time so that the Michaelis–Menten descriptors for
caspase-3 were extracted as well [40]. Similar to this approach, Prasuhn et al.
demonstrated a caspase-3 sensor by utilizing a chemical dye, Texas Red, as the
acceptor molecule [86]. Biswas et al. designed and implemented an alternative
protease sensor for in vivo applications. In this design, elastine-like peptide (ELP)
and TAT sequence were also incorporated in addition to the protease cleavage site,
dye molecules, and quantum dot. The penetration of the quantum dot was carried
out using the ELP peptide and TAT sequence. The quantum dots were conjugated
with an organic dye, Alexa 568, through a cysteine group contained by a peptide
expressing protease cleavage site and attached to ELP and TAT. The quantum dot
conjugate cargo was delivered into the HeLa cells and monitored under
a fluorescence microscopy. Later, the cells were transfected with a proviral plasmid
pNL4-3.HSA.R-E- to induce the production of noninfectious HIV viruses. Follow-
ing the delivery of the quantum dot probe, the cleavage of the peptide with the
HIV-1 Pr was monitored as a decrease in the intensity of Alexa dye. Inhibition of
HIV-1 Pr upon addition of ritonavir, saquinavir, and indinavir was detected as an
increase in the FRET efficiency in a dose-dependent manner [87].
Kinase-enabled protein phosphorylation is recognized as one of the key cellular
processes any dysfunction of the kinases has been related to in the development of
a disease state, and kinases are important for cell signaling and cancer biology.
Ghadiali et al. exploited quantum dot nanocrystals attached with reporter peptides
involving serine, tyrosine, and threonine amino acids, where the attachment was
achieved through using His-tagged peptides. In the existence of kinase, the
corresponding amino acids were phosphorylated, and FRET partner dye-labeled
anti-phospho-amino acid antibody was brought in contact with the quantum dot-
peptide conjugate. While the anti-phospho-amino acid antibody was bound to the
phosphorylated peptides, the quantum dot emitting at 605 and Alexa Fluor emitting
at 670 were brought in close proximity satisfying the FRET conditions [88]. The
same group also constructed another sensor to monitor the activity of the histone
acetyltransferase (p300 HAT). They utilized the same approach for the kinase
sensor and synthesized a target peptide mimicking H4 N terminal histone sequence
including His-tag. The peptide sequence was first incubated with the p300 HAT and
acetylated at the Lys6 position. Later, dye-labeled acetyl lysine specific antibody
recognized the target peptide and was bound to it, causing a FRET-based quenching
of the quantum dot, which was monitored as a sign of HAT activity [89].
Being responsible for the b-lactam antibiotic resistance in bacteria, detection of
b-lactamase is crucial for clinical samples. In their work, Xu et al. proposed
a quantum dot-enabled assay method, which relied on a signal-off type of FRET
interaction. In this approach, CdSe/ZnS quantum dot nanocrystals were decorated
with streptavidin, and the Cy5 dye-conjugated and biotin-modified b-lactam mol-
ecules were synthesized. To eliminate steric hindrance, which arose due to the deep
binding pocket of streptavidin (SA), a linker was also introduced to the b-lactam
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molecules after the biotin modification. After the conjugation of quantum dot-SA
with biotinylated linker-b-lactam-Cy5 complex, the quantum dot emission was
observed to quench indicating the formation of the nanosensor. Meanwhile, the
lactamase was added into the nanosensor solution and, due to the degradation of
b-lactam, Cy5 was released into the solution and diminished the FRET process,
which in turn resulted in an increase in the quantum dot emission (by fourfolds in
this case) [90].
Lipid-coated quantum dots have been developed to be utilized as a probe for
lipid exchange at the cellular interface. In order to understand the capability of the
lipid-coated quantum dot nanocrystals for this purpose, a quantum dot-based
architecture that facilitated FRET process was proposed. This lipid-coated quantum
dot structure was composed of a quantum dot coated with DMPE, a phospholipid
that displayed an available amine group. Through the further modification of the
amine group, an infrared dye Cys5.5 was conjugated to the quantum dot surface.
For a second nanoparticle conjugate to mimic a natural high-density lipoprotein
(HDL), the particle was further incubated with apolipoprotein (apoA 1). First, the
QD-HDL without Cy5.5 was tested for the lipid exchange ability with the
Cy5.5-HDL and Cy5.5-micelles. These two particles were mixed, and it was
observed that because of the exchange of the lipids, Cy5.5 was also transferred to
the QD-HDL structure, which was observed as a decrease in the emission of the
QDs due to the FRET process between the QD and the Cy5.5 dye. The effectiveness
of the Cy5.5-labeled QD-HDL particles was tested for their functionality by
incubating them with living j774a.1 macrophage cells. Upon the adhesion of the
Cy5.5-labeled QD-HDL nanoparticles, Cy5.5-lipid exchange with the cell mem-
brane caused the FRET to disappear. This process was observed in the course of
transferring the quantum dot conjugates from the cell membrane into the cellular
organelles [91]. The schematic of the approach was displayed in Fig. 14.4.
Rakovich et al. realized a FRET facilitating system to increase the light-
harvesting efficiency of the bacteriorhodopsin (bR) embedded into the purple
membranes (PM) of a bacteria Halobacterium salinarum. Quantum dot
nanoparticles conjugated with PM were tested for their effectiveness by monitoring
the FRET-based quenching of the quantum dots. The formation of the FRET-
processing QD-PM assembly increased the light-driven transmembrane pumping
by enhancing light-harvesting capability of bR [92] (Fig. 14.5).
Seker et al. proposed and constructed a film-based biosensing approach where
the quantum dots emitting at 640 nm were used as the acceptor and the quantum
dots emitting at 560 were used as the donor for FRET process. Negatively charged
CdTe quantum dots were layer by layer assembled using polyelectrolytic peptides.
The thermodynamics of the assembly process of the peptides was investigated as
well as the structural features of the peptides to form the most reliable film
combination. Supramolecular assembly of the peptide pairs with different chain
lengths was tested for most reliable design of the FRET facilitating quantum dot
nanocomposites. Once the best peptide constructs were realized, control of the
FRET efficiency was achieved using trypsin enzyme. Trypsin enzyme cleaved
specifically the linker peptides, which triggered the destruction of peptidic thin
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film. In the study, instead of the PL intensities of the donor and acceptor quantum
dots, the change in the fluorescence lifetime of these QDs was used as the readout
signal. Following the release of the donor quantum dots from the peptidic film, the
remaining acceptor quantum dots exhibited a substantially decreased lifetime [93]
(Fig. 14.6).
5.2 Quantum Dot Nanocrystals Enhanced Bioimaging
Quantum dot-based FRET processes were incorporated in many different
biosensing designs, some of which were discussed above. In some of these appli-











Fig. 14.5 The schematic of FRET facilitating lipid-coated quantum dots: (a) HDL-coated QD
and QD micelle with Cy5.5-HDL and Cy5.5-micelle without FRET, (b) Cy5.5 dye exchange
between the HDL-QD and HDL-micelle, and (c) FRET between the Cy5.5 and QD in both
QD-micelle and QD-HDL configuration (Reprinted with permission from Skajaa, T. et al. Quan-
tum Dot and Cy5.5 Labeled Nanoparticles to Investigate Lipoprotein Biointeractions via Forster
Resonance Energy Transfer. Nano Lett 10, 5131–5138 (2010). Copyright (2010) American Chem-
ical Society)
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Fig. 14.4 (a) QD-FRET sensor schematics, (b) spectral properties of the sensor: absorption (pink)
and emission spectra (green) of MBP-conjugated 560QD, along with the absorption spectra (blue)
of beta-CD-QSY9. (c) 560QD-10MBP maltose sensing (Reprinted by permission from Macmillan
Publishers Ltd: [Nature Materials] (79), copyright (2003))
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to monitor any specific cellular process. For imaging applications, the same
approach for constructing biosensors was followed, and the formed constructs of
the quantum dots were delivered into the cells to track cellular function or to deliver
biomolecules or drugs, which were later monitored by the FRET signal in real time.
Shaheen et al. utilized the FRET process involving quantum dots to monitor the
state of the condensation and decondensation of the plasmid DNA (pDNA). pDNA
was attached to the quantum dot nanocrystal, and FRET was achieved between this
conjugate and rhodamine-labeled polycations. The pDNA-polycation core was then
encapsulated into a lipid vehicle, which was called the tetra-lamellar
multifunctional envelope-type nanodevice (T-MEND) to transfect HeLa cells.
Following the penetration of the loaded T-MEND into the cell, the release of the
pDNA was tracked by imaging the change in the FRET signal using a confocal
microscope, which has also scanned the T-MEND device in z-stack to detect the
condensation/decondensation of the pDNA embedded into the T-MEND device.
This method brings about a new and feasible approach for the optimization of the
gene delivery tools for gene therapy using the FRET signal as a guide [94].
Bagalkot et al. constituted a hybrid quantum dot system, which was conjugated
with an A10 RNA aptamer, to recognize the extracellular domain of the prostate-
specific membrane antigen (PSMA). Aptamer-QD conjugate was loaded with an
anticancer drug named as doxorubicin. Studies showed that this system facilitates
two distinct FRET processes. First, a FRET process occurred between the quantum
dot and the doxorubicin molecule, where the quantum dot served as a donor.
Second, a FRET process took place between the aptamer molecules and doxorubi-
cin molecules where the doxorubicin acted as a donor. This multi-FRET system
Fig. 14.6 Peptidic FRET facilitating nanocomposite film: (a) PL decay of the multilayered
structure facilitating FRET, (b) the proteolyic digestion of the peptide film, and (c) PL decay
following the rearrangement of the peptide film as a result of the proteolyic digestion, and (d) PL
decay of the acceptor alone (Reprinted with permission from Seker, U. O. S. et al., Peptide-Mediated
Constructs of Quantum Dot Nanocomposites for Enzymatic Control of Nonradiative Energy Trans-
fer. Nano Letters 11, 1530–1539 (2011). Copyright (2011) American Chemical Society)
552 U.Ö.Ş. Şeker and H.V. Demir
was first delivered into the PSMA-expressing prostate adenocarcinoma cell lines
with the help of A10 RNA aptamer molecule through molecular recognition. After
the delivery of the particle cargo, the doxorubicin was released into the cellular
environment. Release of the doxorubicin reverted the PL emission of the quantum
dot. Upon release of the doxorubicin, PL of doxorubicin was also recovered as it
was dissociated from the A10 RNA aptamer. Therefore, both the delivery of the
quantum dot composite and the release of the drug were monitored through
imaging; additionally, the therapy of the cells was succeeded with the released
drug [95].
The localization of the protein in living cells is important for the protein
distribution. The available techniques can give some idea about the existence of
these proteins but not about their interaction depending on their localization. As
a solution, with the method Kang et al. proposed, it is possible to track the existence
of neighboring proteins. In this work, nucleolin protein was labeled with a dye-
modified aptamer molecule, AS1411 targeting nucleolin. On the other hand,
integrin was marked with a quantum dot nanocrystal. To recognize the integrin,
the quantum dot was decorated with an RGD sequence, which exhibits a high
affinity toward integrin protein. Following the assembly of the quantum dot and dye
molecules, a FRET process between the dye and the quantum dot was tracked.
Using the microscopy analysis, the expression levels of integrin and nucleolin were
determined. This approach allows to co-localize various proteins in a native cell,
which are important to determine the function of some of the important genes [96].
Intracellular imaging of levels of a given material was also achieved using quantum
dot-enhanced FRET, for which Wang et al. used a calcium-modulating protein
(CaM)-QD sensor to track the intracellular Ca+2 level based on FRET [97].
6 Conclusions and Future Perspective
Quantum dot nanocrystals have been exploited in FRET applications for probing
different biological processes. FRET-based labeling systems were designed typi-
cally using quantum nanocrystal as the donors, while the organic dye molecules or
fluorescent proteins were utilized as the acceptors. Also nanoparticles like silica
nanoparticles and gold nanoparticles were used as the acceptor species. To satisfy
the FRET conditions, donors and acceptors were conjugated using different
approaches. Most popularly, the quantum dots and acceptor species were conju-
gated using a chemical bonding approach, where the carboxyl-functionalized quan-
tum dots were activated using NHS/EDC and then active amine-binding quantum
dots were linked. Streptavidin-coated quantum dots were also commonly conju-
gated with the biotin-labeled acceptors, or as an alternative approach, the conjuga-
tion was obtained using electrostatic interaction between the quantum dot donors
and dye acceptors.
Many assays were designed and realized for quantum dot-based FRET applica-
tions. Antibody–antigen interactions, protein–protein interactions, and enzymatic
activities were successfully monitored using quantum dot-enabled FRET systems,
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where a pre-quenched quantum dot was typically used as the donor and an increase
in the quantum dot PL was observed upon interaction of the targeted entities.
Similarly, in the design of molecular beacons or DNA-hybridization assays, the
same approach was used, which is commonly known as the signal-off mode FRET
system. Additionally, another FRET mode, in which initially the quantum dot
emission was not quenched and the acceptor was not in the close proximity of the
donor or was quenched by a secondary acceptor due to its interaction with another
molecule, the FRET conditions were later satisfied only upon the interaction with
the targeted molecule.
Most of the previous studies in the literature focused on using the quantum dot
nanocrystals as the donor molecules because of their long fluorescence lifetime,
which makes the resulting FRET efficiency higher. Although there are challenges in
using quantum dots as the acceptors, utilizing biological reactions (e.g., those based
on chemoluminescence and bioluminescence) can enable the quantum dots to emit
in the absence of a physical light. This kind of approaches can lead to the
development of innovative bioassay systems.
Although there have been fascinating efforts put into action to improve the
capabilities of the quantum dots, there are still challenges especially for the
in vivo delivery of these dots. There have been numerous different approaches
and tools developed and optimized for a simple delivery of the quantum dots.
Utilization of lipid transfection, direct microinjection, and electroporation are
among the widely studied approaches in this area [98–100]. The surface chemistry
of the quantum dots affects the delivery in the cellular environment. For that reason,
utilization of protein and peptide-integrated quantum dots is becoming more
important. Biomolecules are generally recognized to be biocompatible compared
to the chemical linkers. For example, signaling molecule-functionalized quantum
dots can be used for the transportation of the quantum dots across the cellular
membrane to the nucleus of the cells.
FRET-based approaches to track any given biochemical reaction occurring
within the cell are capable of creating a new era for the proteomics. Given the
fact that metabolic engineering needs real time monitoring of the metabolic flux
analysis of a molecule of interest, quantum dots can be used to construct in vitro
assays facilitating FRET. Not only for diagnosis but also for therapy, the quantum
dots could be successfully utilized while carrying drug cargo into the target cell
compartment, and the real time delivery of the drug molecule and its effectiveness
could be monitored. In this way, the quantum dot FRET-based drug screening
approaches could possibly be established. However, there is one important chal-
lenge to be addressed about their toxicity. In order to bear with the toxicity of the
quantum dots, various attempts were made using cell-based experiments focused on
the fate of the quantum dots within the cell, especially about distribution and
accumulation of the quantum dots [101–103]. To overcome these disadvantages,
strategies were tested to reduce toxicity of the quantum dots including negatively
charged surface and biocompatible surface coatings. Another reported approach
was based on using less toxic materials instead of Cd for the synthesis of semicon-
ductor nanoparticles such as ZnO and ZnSe [104, 105].
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To sum up, semiconductor colloidal quantum dots make one of the most popular
and promising tools in biomedical and biochemical applications, potentially
enabling game-changing detection and imaging systems for life sciences. Quantum
dot-based FRET applications allow for the flexibility of carrying out detection and
imaging studies at a wide range of wavelength choice at high efficiency levels with
their broadband absorption and long fluorescence lifetimes, compared to the avail-
able organic dyes. With the ease of their surface functionalization, the colloidal
quantum dots are capable of serving as efficient FRET donors for a wide range of
applications with a potential high impact of emerging commercial production lines
toward biomedical diagnostic and therapy tools.
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